Sun Pharma gets 8 observations from USFDA for Halol facility

The US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1688.70 as compared to the previous close of Rs. 1687.00. The total number of shares traded during the day was 42174 in over 2842 trades.

The stock hit an intraday high of Rs. 1699.50 and intraday low of 1652.35. The net turnover during the day was Rs. 71052428.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 USFDA GMPInspection HalolFacility Form483 8Observations